Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-02 @ 8:48 AM
Study NCT ID:
NCT00003269
Status:
COMPLETED
Last Update Posted:
2011-01-10
First Post:
1999-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Sponsor:
Scripps Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000066165
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
James R. Mason, M.D.
Old Organization:
Scripps Health